Compare Pfizer with JUBILANT LIFE SCIENCES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs JUBILANT LIFE SCIENCES - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER JUBILANT LIFE SCIENCES PFIZER/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x 36.5 13.5 270.3% View Chart
P/BV x 6.2 1.7 365.1% View Chart
Dividend Yield % 0.6 0.9 62.8%  

Financials

 PFIZER   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    PFIZER
Mar-19
JUBILANT LIFE SCIENCES
Mar-19
PFIZER/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs3,840898 427.6%   
Low Rs2,080618 336.8%   
Sales per share (Unadj.) Rs455.0572.0 79.5%  
Earnings per share (Unadj.) Rs93.836.2 258.9%  
Cash flow per share (Unadj.) Rs109.459.5 183.8%  
Dividends per share (Unadj.) Rs22.504.50 500.0%  
Dividend yield (eoy) %0.80.6 128.0%  
Book value per share (Unadj.) Rs658.2301.9 218.0%  
Shares outstanding (eoy) m45.75159.28 28.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.51.3 491.1%   
Avg P/E ratio x31.620.9 150.9%  
P/CF ratio (eoy) x27.112.7 212.5%  
Price / Book Value ratio x4.52.5 179.2%  
Dividend payout %24.012.4 193.1%   
Avg Mkt Cap Rs m135,420120,694 112.2%   
No. of employees `0002.62.4 110.1%   
Total wages/salary Rs m3,23819,260 16.8%   
Avg. sales/employee Rs Th7,911.438,120.6 20.8%   
Avg. wages/employee Rs Th1,230.98,058.4 15.3%   
Avg. net profit/employee Rs Th1,630.72,414.3 67.5%   
INCOME DATA
Net Sales Rs m20,81591,108 22.8%  
Other income Rs m1,674357 468.4%   
Total revenues Rs m22,48991,466 24.6%   
Gross profit Rs m5,71217,390 32.8%  
Depreciation Rs m7143,709 19.2%   
Interest Rs m732,198 3.3%   
Profit before tax Rs m6,59911,840 55.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-2,802 0.0%   
Tax Rs m2,3093,268 70.6%   
Profit after tax Rs m4,2915,770 74.4%  
Gross profit margin %27.419.1 143.8%  
Effective tax rate %35.027.6 126.8%   
Net profit margin %20.66.3 325.5%  
BALANCE SHEET DATA
Current assets Rs m27,16745,848 59.3%   
Current liabilities Rs m8,91720,897 42.7%   
Net working cap to sales %87.727.4 320.2%  
Current ratio x3.02.2 138.9%  
Inventory Days Days6857 119.4%  
Debtors Days Days3051 59.1%  
Net fixed assets Rs m8,86265,498 13.5%   
Share capital Rs m458159 287.2%   
"Free" reserves Rs m29,65647,930 61.9%   
Net worth Rs m30,11348,089 62.6%   
Long term debt Rs m2542,429 0.1%   
Total assets Rs m39,400114,685 34.4%  
Interest coverage x91.56.4 1,433.0%   
Debt to equity ratio x00.9 0.1%  
Sales to assets ratio x0.50.8 66.5%   
Return on assets %11.16.9 159.4%  
Return on equity %14.212.0 118.7%  
Return on capital %22.112.4 178.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m42812,422 3.4%   
Fx outflow Rs m78617,227 4.6%   
Net fx Rs m-358-4,805 7.5%   
CASH FLOW
From Operations Rs m97811,215 8.7%  
From Investments Rs m351-10,118 -3.5%  
From Financial Activity Rs m-1,0996,574 -16.7%  
Net Cashflow Rs m2317,612 3.0%  

Share Holding

Indian Promoters % 0.0 45.6 -  
Foreign collaborators % 63.9 3.5 1,825.7%  
Indian inst/Mut Fund % 7.5 8.7 86.2%  
FIIs % 4.9 21.2 23.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 21.1 112.3%  
Shareholders   85,207 23,815 357.8%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   PANACEA BIOTECH  BIOCON   FULFORD INDIA  NATCO PHARMA  AJANTA PHARMA  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Hits Fresh Record High; Vodafone Idea Among Top Gainers(12:30 pm)

After opening the day on a positive note, share markets in India continued their momentum to hit a fresh record high.

Related Views on News

JUBILANT LIFE SCIENCES Announces Quarterly Results (2QFY20); Net Profit Up 18.9% (Quarterly Result Update)

Oct 31, 2019 | Updated on Oct 31, 2019

For the quarter ended September 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 18.9% YoY). Sales on the other hand came in at Rs 23 bn (down 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY20); Net Profit Down 7.7% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 7.7% YoY). Sales on the other hand came in at Rs 22 bn (up 5.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Nov 20, 2019 12:51 PM

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS